We are live on
!
Find out more
DY
Dowling & Yahnke Portfolio holdings
AUM
$2.15B
Turnover
6.98%
1-Year Est. Return
10.82%
This Fund
S&P 500
This Quarter
Est. Return
-4.54%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
–
AUM
$2.15B
AUM Growth
+$21.9M
(+1%)
Cap. Flow
+$140M
Cap. Flow
% of AUM
6.52%
Top 10 Holdings %
Top 10 Hldgs %
29.72%
Holding
387
New
13
Increased
178
Reduced
139
Closed
14
Avg Time Held
5.5
years
Top 10 Avg Time Held
1.8
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional International Core Equity Market ETF
DFAI
|
+$30.3M |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$24.2M |
| 3 |
Vanguard Total International Stock ETF
VXUS
|
+$23.3M |
| 4 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$13.8M |
| 5 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
+$10.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$16.8M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$4.06M |
| 3 |
Northrop Grumman
NOC
|
+$2.81M |
| 4 |
Leidos
LDOS
|
+$2.15M |
| 5 |
Saic
SAIC
|
+$1.57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.91% |
| 2 | Technology | 10.65% |
| 3 | Healthcare | 9.36% |
| 4 | Financials | 6.57% |
| 5 | Consumer Staples | 5.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Mondelez International
MDLZ
$80.4B
| $5.07M | 0.24% |
92,404
+219
| +0.2% | +$13.6K |
2013 Q2
37 quarters
|
|
102
Sempra
SRE
$53.6B
| $5M | 0.23% |
66,628
+13,184
| +25% | +$1.07M |
2016 Q4
23 quarters
|
|
103
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13.1B
| $4.99M | 0.23% |
62,877
-13,979
| -18% | -$1.19M |
2017 Q4
19 quarters
|
|
104
Vanguard Morningstar Large-Cap ETF
VV
$54.8B
| $4.86M | 0.23% |
29,736
+1,156
| +4% | +$210K |
2013 Q2
37 quarters
|
|
105
Nike
NKE
$55.2B
| $4.79M | 0.22% |
57,655
-539
| -0.9% | -$58K |
2013 Q2
37 quarters
|
|
106
iShares Russell 2000 Growth ETF
IWO
$13.7B
| $4.79M | 0.22% |
23,189
+268
| +1% | +$60.3K |
2013 Q2
37 quarters
|
|
107
Vanguard Health Care ETF
VHT
$19.9B
| $4.78M | 0.22% |
21,388
+672
| +3% | +$160K |
2013 Q2
37 quarters
|
|
108
iShares Micro-Cap ETF
IWC
$1.28B
| $4.76M | 0.22% |
46,055
-1,433
| -3% | -$163K |
2013 Q2
37 quarters
|
|
109
DexCom
DXCM
$33.1B
| $4.76M | 0.22% |
59,056
+88
| +0.1% | +$7.45K |
2014 Q1
34 quarters
|
|
110
US Bancorp
USB
$89.4B
| $4.61M | 0.21% |
114,381
-709
| -0.6% | -$32.8K |
2013 Q2
37 quarters
|
|
111
State Street Utilities Select Sector SPDR ETF
XLU
$24.1B
| $4.45M | 0.21% |
135,846
+290
| +0.2% | +$10.6K |
2013 Q2
37 quarters
|
|
112
Broadcom
AVGO
$1.64T
| $4.38M | 0.2% |
98,710
+330
| +0.3% | +$16.9K |
2015 Q4
27 quarters
|
|
113
Chevron
CVX
$430B
| $4.31M | 0.2% |
29,988
+61
| +0.2% | +$9.3K |
2013 Q2
37 quarters
|
|
114
Salesforce
CRM
$203B
| $4.16M | 0.19% |
28,944
+330
| +1% | +$56K |
2013 Q3
36 quarters
|
|
115
Dimensional World ex US Core Equity 2 ETF
DFAX
$12.2B
| $4.08M | 0.19% |
216,189
+4,338
| +2% | +$92.1K |
2021 Q3
4 quarters
|
|
116
IBM
IBM
$221B
| $4.02M | 0.19% |
33,868
+1,057
| +3% | +$139K |
2013 Q2
37 quarters
|
|
117
Charles Schwab
SCHW
$163B
| $3.98M | 0.19% |
55,440
+643
| +1% | +$44.6K |
2013 Q2
37 quarters
|
|
118
Colgate-Palmolive
CL
$73.9B
| $3.98M | 0.19% |
56,586
+493
| +0.9% | +$38.7K |
2013 Q2
37 quarters
|
|
119
Blackrock
BLK
$174B
| $3.96M | 0.18% |
7,203
-54
| -0.7% | -$35.3K |
2014 Q1
34 quarters
|
|
120
Vanguard FTSE Developed Markets ETF
VEA
$228B
| $3.92M | 0.18% |
107,847
+2,209
| +2% | +$90K |
2013 Q2
37 quarters
|
|
121
iShares Core S&P 500 ETF
IVV
$889B
| $3.86M | 0.18% |
10,753
+426
| +4% | +$170K |
2013 Q2
37 quarters
|
|
122
Vanguard Extended Market ETF
VXF
$30.1B
| $3.79M | 0.18% |
29,801
+2,693
| +10% | +$380K |
2013 Q2
37 quarters
|
|
123
PNC Financial Services
PNC
$85.7B
| $3.75M | 0.17% |
25,115
+449
| +2% | +$72.7K |
2013 Q2
37 quarters
|
|
124
Illinois Tool Works
ITW
$77.2B
| $3.71M | 0.17% |
20,553
+102
| +0.5% | +$20.1K |
2013 Q2
37 quarters
|
|
125
Intel
INTC
$504B
| $3.67M | 0.17% |
142,379
-23,022
| -14% | -$785K |
2013 Q2
37 quarters
|
|
Similar funds
AC
APA
IC
SCA
ACM
W
Dowling & Yahnke's Q3 2022 Portfolio in Review
As of Q3 2022, Dowling & Yahnke held 387 positions worth $2.15B, up 1% from $2.13B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Dowling & Yahnke deployed $140M of net new capital in Q3 2022, opening 13 new positions and adding to 178 existing holdings. Its largest new stake was U.S. High Relative Profitability Portfolio ETF Class Shares: 161,010 shares worth $3.44M.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 49% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Tax-Exempt Bond Index Fund, an estimated $16.8M trimmed.
- Dowling & Yahnke's largest Q3 2022 buy was U.S. High Relative Profitability Portfolio ETF Class Shares: 161,010 shares worth $3.44M.
- Dowling & Yahnke added most to Dimensional International Core Equity Market ETF in Q3 2022, an estimated $30.3M increase.
- Dowling & Yahnke's biggest Q3 2022 reduction was Vanguard Tax-Exempt Bond Index Fund, cutting an estimated $16.8M.
- Dowling & Yahnke fully exited Saic in Q3 2022, selling an estimated $1.57M.
- Dowling & Yahnke's ten largest holdings make up 30% of its $2.15B portfolio in Q3 2022.
- Dowling & Yahnke opened 13 new positions and closed 14 in Q3 2022.
- Dowling & Yahnke's portfolio value rose 1% quarter-over-quarter to $2.15B.
Based on Dowling & Yahnke's 13F filing for Q3 2022, filed 3 Nov 2022.